CTOs on the Move

MacAndrews and Forbes

www.mafgrp.com

 
MacAndrews and Forbes Incorporated owns and operates a diverse array of businesses, tapping into the broad expertise of its management team to support the delivery of best in class products and services to end users and consumers all over the world. Wholly owned by Chairman and Chief Executive Officer Ronald O. Perelman, MacAndrews and Forbes’ primary objective is to build, run, and grow great businesses. Our core strategy is to focus our business lines on strong market positions, high quality management with vertical expertise, recognized growth potential and ability to increase productivity. MacAndrews and Forbes’ businesses span a wide range of industries, ...
  • Number of Employees: 50K-100K
  • Annual Revenue: $500M-1 Billion
  • www.mafgrp.com
  • 35 East 62nd Street
    New York, NY USA 10065
  • Phone: 212.572.8600

Executives

Name Title Contact Details
Kurt Steege
Chief Information Officer Profile

Similar Companies

SoftBank Investment

At SoftBank Investment Advisers, we believe the next stage of the Information Revolution is underway. Through the SoftBank Vision Fund, we are investing up to $100 billion in the businesses and technologies that will help make it possible. We offer the operational expertise, global network and patient capital required to help exceptional founders build market-leading companies. We are committed to building a world-class organization. If you`re interested in a role with any of the SoftBank Investment Advisers entities, we want to hear from you. "SoftBank Investment Advisers" refers to SB Investment Advisers (UK) Limited, a registered investment adviser and its two sub-advisors: SB Investment Advisers (US) Inc. and SB Investment Advisers (Japan) Corp. SoftBank Investment Advisers serves as Adviser to the SoftBank Vision Fund

SAC Capital Advisors

SAC Capital Advisors is a Stamford, CT-based company in the Financial Services sector.

Omega Fund

Omega Funds is a leading international investment firm that creates and invests in life sciences companies that target the world`s most urgent medical needs. Ω is the last letter of the Greek alphabet. Our investment process starts by focusing on the end goal – delivering impactful medicines to patients. We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas, including oncology, immunology, rare diseases, precision medicine and others. Early seed or late stage public financing. Large markets or rare diseases. Established targets or novel technologies. We are guided by our conviction in people, products and breakthrough ideas, not by conventional categories. Our investments span a variety of instruments from early venture rounds, to late-stage investing, direct secondary transactions, as well as company founding and creation. Omega Funds has raised more than $1 billion since its inception in 2004 and is headquartered in Boston, Massachusetts, USA.

Radicle Growth

Radicle is an acceleration fund dedicated to disrupting the world of agriculture and food by discovering innovative entrepreneurs and emerging technologies in the food and agriculture industry. The Acceleration Fund solves some of the most pressing issues facing the earth today by reducing the time to bring the latest Ag technologies to market. The fund is focused on tackling global farming problems by investing and accelerating companies in the areas of Digital Ag, Biologicals, New Farm Systems and Seed Technology. Founding members include Finistere Ventures, a $150M AgTech venture fund, Bayer, a $51B global life science and agriculture conglomerate, DowDuPont Pioneer, a $25B global science and engineering company and OurCrowd, a $250M leading funding platform and Cloud Break Advisors, a global acceleration platform.

Sanders Morris Harris Group

Sanders Morris Harris Group Inc. (SMHG), through its subsidiaries and affiliates, provides asset